Transcriptomics

Dataset Information

0

Transcription factor LIM1 progresses tumor growth in endometrial cancer via CREB signaling.


ABSTRACT: The incidence of endometrial cancer (EC) is increasing worldwide, however, therapeutic options for EC are limited and novel therapeutic targets for EC are required. We reanalyzed RNA-seq data of EC registered in The Cancer Genome Atlas and found significant upregulation of transcription factor LIM homeobox1 (LIM1) in stages II-IV compared to stage I of EC patients. LIM1-knocked down (LIM1-KD) and Control sublines were established using HEC50B cell line and then RNA-sequence results were analyzed by Ingenuity pathway analysis (IPA). It revealed enrichment of CREB signaling-related genes among differentially expressed genes between Control and LIM1-KD sublines. Also, decreased levels of phosphorylated CREB were observed in LIM1-KD subline. In the Xenograft model used by HEC50B sublines, tumor growth was significantly suppressed in the LIM1-KD subline compared to Control subline. Immunofluorescent staining showed decreased phosphorylation of CREB in LIM1-KD-derived tumors. Kaplan-Meier plotter analysis indicated that the high LIM1 expression group had a significantly poorer prognosis. These results suggest that LIM1 in EC progresses tumor growth and malignancy via CREB signaling.

ORGANISM(S): Homo sapiens

PROVIDER: GSE215413 | GEO | 2022/10/16

REPOSITORIES: GEO

Similar Datasets

2010-06-08 | E-GEOD-16554 | biostudies-arrayexpress
2010-06-01 | GSE16554 | GEO
2015-05-01 | GSE56908 | GEO
2023-01-15 | GSE143689 | GEO
2014-01-17 | GSE54175 | GEO
2008-07-18 | GSE12119 | GEO
2017-07-24 | GSE101579 | GEO
2011-11-10 | E-GEOD-33570 | biostudies-arrayexpress
2020-05-08 | GSE150083 | GEO
2020-05-08 | GSE150025 | GEO